Events

Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate your bacteriophage research into targeted therapeutics that demonstrate clinically significant results.We have also added a new dimension for this year's meeting with the addition of our Pre-Conference Non-Human Application Focus Daywhich will touch on the use of phages within the agricultural, livestock and food safety industries.

SMi present’s its 15th annual Parallel Trade virtual conference, taking place virtually on the 22nd and the 23rd March 2021. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. The 2021 event will be more significant than ever before due to the transition period after Brexit coming to an end this year. As such, the UK will no longer be part of the EU free market. This will mean increased medicines prices, reduced access to some specialist drugs and greater risk of supply chain shortages. In a post-Brexit environment, exhaustion of rights will cease to apply to the UK, making import and export a costly business and in a worst-case…

Gastroenterology and Hepatology Congress will offer opportunity for physicians, researchers, allied healthcare professionals and clinical gastroenterologists to discuss the latest advancements in GI and translate them into new treatment strategies to improve clinical care. Target Audience: Gastroenterologists Hepatologists Pancreas and Liver Specialist Endocrinologists Oncologists Laparoscopic Surgeons General Physicians Academicians and Researchers Clinical Nurses Medical Students Conference Central Topics: Clinical Challenges in GI Gastrointestinal Immunology Gastrointestinal Cancers Gastroenterology and Hepatology Gastroenterology and Endocrinology Digestive & Metabolic Health Pediatric Gastroenterology and Nutrition Hepto-Nephrology and Pathology Hepatitis, Liver Diseases and Pr…

Boston, U.S.A, Massachusetts, MA, 02101, Boston, U.S.A

International Pharmaceutical Business Expo- iPharma Expo 2021 scheduled during March 19-20, 2021 at Boston, U.S.A. iPharma Expo 2021 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry.     This expo will showcase the latest trends and technologies in pharmaceuticals, drugs and formulations and will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries.  Register  for free at https://www.ipharmaexpo.com/visitor-registration/    iPharma Expo 2021 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry & management etc.  Brings unique platform for the participa…

2020 World Heart and Cardiothoracic Surgery Conference (2020WHCS) is a premiere educational Heart Congress in the field of Cardiothoracic Surgery and Cardiology that rotate between continents and are organized in collaboration with national and international Cardiac societies and associations. This International Heart and Cardiothoracic Surgery Congress 2020WHCS is going to be held at Bangkok, Thailand during March 19-20, 2021 around the theme ‘Discovering the Science of Heart’. The World Heart and Cardiothoracic Surgery Conference is targeted to the international Cardiology, Cardiac Surgery and Cardiovascular community as well as the other healthcare professionals involved in multidisciplinary Heart Care; thus, enabling professionals from worldwide to exchange their views on a wide variet…

4th Annual Pharma Regulatory Summit 2021 18th March 2021, Virtual Conference (Time Zone - IST)   Greetings from Virtue Insight, Join 4th Annual Pharma Regulatory Summit 2021 virtual conference and engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in India. Virtue Insight brings you an interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives. Join us to discuss multi-regional cooperation, global harmonization, and best practices related to India’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure certainty in India and strategic initiatives to improve colla…

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact. Why You Should Attend On one hand, there is a strong need from pharma customers (physicians, but also patients, nurses, (hospital) pharmacists etc.) to receive the latest medical information “anytime, anywhere” – on websites, but also on tablet devices and smartphones. On the other hand, pharma is experiencing cost pressures in the promotional space. As a result, more efforts are being put into blended or pure online offerings, which not only result in budget efficiencies, but will also be preferred by time-pressured customers.&nbs…

Understand the terminology, tools, models and argumentation used in cost-effectiveness studies/articles – Learn to distinguish good from bad ones – Know how HECON studies should be integrated into clinical & marketing plans – Understand how payers assess and use HECON evaluations Why You Should Attend The Content: This health economics course not only provides you with an explanation of concepts and methods, it also discusses the integration of health economic evaluations in clinical development and brand marketing plans (with practical examples), as well as the perspective of the decision maker - including examples of successful applications of health economic evaluations. The Expert: Prof. Dr. Lieven Annemans not only has a wide international experience…

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development. Why You Should Attend In the past, pharma companies were largely fuelled by their own R&D departments developing small-molecule solutions to large patient populations. In that era, sales and marketing took the lead and scientific concerns were very much secondary to promotion.  Medical affairs departments were often a back-office service that made sure the marketing heroes did not let their exuberance for the brand take them t…

Conference: 15 – 16 March 2021Virtual Conference: Online Access Only  Website:  Chaired by: Darren Green, Director of Molecular Design & Senior Fellow, GSK Sponsored by: OpenEye Scientific Software   SMi is proud to present its 2nd Annual AI in Drug Discovery Conference, taking place on the 15-16 March 2021. With the global Artificial Intelligence (AI) in Drug Discovery Market size expected to exceed $3,900 million by 2027, the conference agenda will encompass key drivers leading the way into a shorter, cheaper, and more successful R&D era. The conference will be a particular focus on case studies from leading pharma and biotech, as well as a close-up view on the paradigm shift from undruggable targets to ‘challenging to drug’. Furthermore the event will focus o…

With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting time to be targeting misfolding diseases. We’ll be bringing together expert researchers and industry leaders to answer your burning questions; taking a look at the delivery of biologics across the blood brain barrier, exploring the underlying chemical biology of protein conformation diseases and hearing what new approaches are emerging to combat misfolding disorders in a variety of therapeutics areas. Improve pre-clinical predictability by hearing what disease models are now considered best practice with Beth Hoffman, Founder and CEO, Origami Therapeutics and understand how Pfizer develops ph…

Targeting RNA is set to be the next big thing; 85% of human genome transcribed to RNA but only 3% translated into proteins, therefore making it an obvious target. With Risdiplam being approved by the FDA in August, and several major collaborations also being penned throughout 2020, including a $190 million deal between Arrakis and Roche, it seems like a good time to target these protein precursors.  Targeting RNA 2021 will take a look at the latest techniques to analyse and predict protein structure, as well as hearing from leading researchers and industry on how to incorporate learnings from RNA biology into potent and selective ligands to help prevent, rather than treat, disease. Key outcomes include:  Hear how Cryo EM, 3D visualisation and novel structural techniques can be u…

Healthy Eating for a Healthy a Healthy Weight Protignes Conferences is hosting the Obesity & Diet Management Conference at Bali on the 15th & 16th of March 2021. Carrying the theme of ‘Healthy Eating for a Healthy Weight’ we aim to create awareness and understanding regarding obesity and the importance of eating healthy. The Obesity Conference will cover the important topics associated with nutrition, diet and weight management. We have slots available for Speakers, Delegates, Poster authors, Exhibitors. Book your slot at the earliest and avail discounted accommodation in Bali. To promote your organization and collaborate with our obesity event contact us at: Email: hello@protignes.com Ph: +91-8971433223 http://obesity.protignes.com/index.php

4th Annual Pharma AI, IoT & Blockchain 2021 Integrating AI, IoT, Blockchain & Big Data in Pharma & Healthcare 11th March 2021, Virtual Conference (TimeZone – GMT) This conference will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of technology impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. DELEGATE REGISTRATION: Email: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779 Please note that this is a PAID event and NOT A FREE event (no complimentary passes a…

The US is the largest market globally for pharmaceutical sales, so having a good understanding of FDA procedures is vital for those submitting in this challenging region. This course will help clarify the US regulatory process, giving you a practical insight into FDA requirements and ensuring that you are fully up to date with all the latest developments. The comprehensive programme will cover procedures for submission of INDs, NDAs, ANDAs and 505(b)(2), provide a useful insight into the organisation and structure of the FDA and its review processes, and highlight recent changes. The course will emphasise areas of interest to innovative manufacturers, but will also deal with issues relating to generic and over-the-counter drugs. There will be ample opportunity for discussion with our exper…

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Natalie Newell. Why You Should Attend Behavioural science, and in particular the science of patient health behaviours, is the new buzz in pharma’s patient-centric community. Whilst the challenge of non-adherence has been around for as long as medications exist, successful efforts to address the challenge have been scarce. This is primarily due to a lack of knowledge in two areas: W…

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal Why You Should Attend The Content: Business Development in the pharmaceutical industry has become the most significant source of new products for most pharmaceutical companies. It is now conducted throughout every organisation, which requires executives in many disciplines to understand the process. Even executives new in a business development role often have had no formal training. Companies need to have a structured process throughout the organisation to ensure that there is coordination of efforts and alignment of strategy. This course has been writ…

Before placing a medical device on the European market, manufacturers need to produce technical documentation providing evidence of conformity with the relevant legislation. From the 26 May 2020, technical documentation needs to comply with the Medical Device Regulation (MDR) (EU) Regulation 2017/745. Manufacturers’ who already have products on the market under the MDD (Medical Device Directive) or AIMDD (Active Implantable Medical Device Directive) who wish to obtain or renew a CE certificate or issue a Declaration of Conformity (DoC), will eventually have to revise their technical documentation to comply with the MDR at the latest by 27 May 2024. Furthermore, manufacturers of In-Vitro Diagnostic Devices will also need to revise their technical documentation to comply with the In-Vitro Di…

The market for orphan drug products continues to expand and developing new treatments for rare diseases is becoming an increasingly important growth area for many pharmaceutical companies. This interest in rare and orphan diseases is linked not only to the incentives offered by the different regulatory authorities but also to the recent development of advanced therapies. The interactive course will cover all the key aspects of orphan drug legislation in both the US and EU and the regulatory processes designed to enable early access to innovative medicines. The programme will help you to assess the strategic considerations of when to apply for orphan designation and to which agency and look at the development of advanced therapies and using orphan drug designation with your ATMP strategy. A…

Injectable drug delivery is considered to be one of the most effective routes of administration due to the speed and effectiveness of delivery to the target, and recent developments have improved the patient experience. The global injectable drug delivery market continues to grow and technology is advancing. This, coupled with the ever-changing regulatory requirements, means that it is imperative for companies to stay abreast of the latest developments and challenges within the industry in order to remain compliant, as well as gaining a competitive edge. This seminar has been designed to provide all those working in the industry with the latest information on the next generation of injectable drugs and devices and an update on recent trends, technologies and applications. It will also be a…